RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • Regulatory NewsRegulatory News

    FDA Allows Banned Chinese Firm to Ship Chemotherapy to US as Shortage Threat Looms

    [Editor's note on 2/19/16: FDA spokesman Stephen King has since offered additional comment though he could not confirm whether or not this comment applies to Zhejiang Hisun or what the company has done to ensure that the API it's allowed to send to the US is not manufactured in the same way as the APIs that are banned from entering the US .  "When FDA exempts certain drugs from an import alert due to shortage concerns, the agency also often requests the manufacturer to ...